Effects of shuxuetong injection for cerebral infarction: A protocol for systematic review and meta-analysis

BACKGROUND: Cerebral infarction (CI) is a common disease with high morbidity and disability. Shuxuetong (SXT) injection is a Chinese Materia Medica standardized product used in the treatment of CI. Currently, there is a lack of high-quality evidence to support the effectiveness and safety of SXT on...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Hua, Zhou, Honglong, Zhang, Jicai, Li, Ziyi, Chen, Zhen, Yuan, RaoRao, Huang, Xiangqun, Yang, Junyong, Zhang, Jianqiang, Wang, Shuo, Huang, Yong, Hu, Shangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458199/
https://www.ncbi.nlm.nih.gov/pubmed/32871932
http://dx.doi.org/10.1097/MD.0000000000021929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458199/
https://www.ncbi.nlm.nih.gov/pubmed/32871932
http://dx.doi.org/10.1097/MD.0000000000021929

Ejemplares similares